GSK sets 2026 results and dividend timetable

GSK plc outlines its financial reporting and dividend timetable for the remainder of 2026.

Rhea-AI Filing Summary

GSK plc outlines its financial reporting and dividend timetable for the remainder of 2026. The company plans to publish its Q2 2026 results on Tuesday 28 July 2026 via the London Stock Exchange and will also provide an update on portfolio growth opportunities at that time.

The schedule lists announcement, ex-dividend, record, dividend election and payment dates for Q2, Q3 and Q4 2026. For Q2 2026, the cash dividend is scheduled to be paid on Thursday 8 October 2026, for Q3 2026 on Thursday 7 January 2027, and for Q4 2026 on Thursday 8 April 2027. All dates are described as indicative and may be subject to change.

Key Figures

Q2 2026 results announcement: Tuesday 28 July 2026 Q2 2026 dividend payable date: Thursday 8 October 2026 Q3 2026 dividend payable date: Thursday 7 January 2027 +4 more

7 metrics

Q2 2026 results announcement Tuesday 28 July 2026 Planned publication date via London Stock Exchange

Q2 2026 dividend payable date Thursday 8 October 2026 Dividend payment date for Q2 2026

Q3 2026 dividend payable date Thursday 7 January 2027 Dividend payment date for Q3 2026

Q4 2026 dividend payable date Thursday 8 April 2027 Dividend payment date for Q4 2026

Q2 2026 DRIP election deadline Thursday 17 September 2026 Last date for DRIP elections for Q2 2026

Q3 2026 DRIP election deadline Monday 14 December 2026 Last date for DRIP elections for Q3 2026

Q4 2026 DRIP election deadline Tuesday 16 March 2027 Last date for DRIP elections for Q4 2026

Key Terms

American Depositary Shares, Ex-dividend date, Record date, DRIP elections, +1 more

5 terms

American Depositary Shares financial

"Ordinary Shares Ex-dividend date | American Depositary Shares Ex-dividend date"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Ex-dividend date financial

"Ordinary Shares Ex-dividend date | American Depositary Shares Ex-dividend date"

The ex-dividend date is the date when a stock starts trading without the value of its next dividend payment included. If you buy the stock on or after this date, you won't receive that upcoming dividend; only those who owned the stock before this date are entitled to it. It matters to investors because it determines who is eligible to receive the dividend and can influence the stock’s price around that time.

Record date financial

"Record date | Last date for DRIP elections | Payable"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

DRIP elections financial

"Last date for DRIP elections | Payable"

depositary receipts financial

"American Depositary Shares Ex-dividend date"

A depositary receipt is a certificate issued by a bank that represents ownership of shares in a foreign company and can be bought and sold on a local stock exchange. Think of it as a proxy share held in a safe abroad so investors can trade and receive dividends in their own market and currency, making it easier to access foreign companies while exposing investors to the issuer’s underlying business and cross‑border risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will GSK (GSK) release its Q2 2026 results?

GSK plans to publish its Q2 2026 results on Tuesday 28 July 2026. The release will be made via the London Stock Exchange and will include an update on the company’s portfolio growth opportunities alongside the quarterly financial information.

What is the Q2 2026 dividend payment date for GSK (GSK)?

The Q2 2026 dividend for GSK is scheduled to be paid on Thursday 8 October 2026. This follows a record date of Friday 14 August 2026 and a last date for DRIP elections of Thursday 17 September 2026.

What are the key Q3 2026 dividend dates for GSK (GSK)?

For Q3 2026, GSK’s dividend timetable includes a record date of Friday 13 November 2026 and a last date for DRIP elections of Monday 14 December 2026. The Q3 dividend is expected to be paid on Thursday 7 January 2027, subject to possible changes.

What are the main Q4 2026 dividend dates for GSK (GSK)?

For Q4 2026, GSK lists a record date of Friday 19 February 2027 and a last date for DRIP elections of Tuesday 16 March 2027. The Q4 2026 dividend is scheduled to be paid on Thursday 8 April 2027, with all dates described as indicative.

Will GSK (GSK) provide any strategic updates with Q2 2026 results?

Yes, alongside publishing Q2 2026 results on Tuesday 28 July 2026, GSK plans to provide an update on portfolio growth opportunities. This suggests additional context on how the company views future growth drivers within its business portfolio.

Are GSK’s 2026 dividend and results dates fixed or subject to change?

GSK states that all listed dates for results announcements, ex-dividend dates, record dates, DRIP deadlines and dividend payments are indicative. This means they may be subject to change, so investors should note that the timetable is not guaranteed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 07:19 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc

GSK confirms that the Company's Q2 2026 results are due to be published via the London Stock Exchange on Tuesday 28 July 2026. GSK will also provide an update on portfolio growth opportunities.

The results announcement dates and respective record and dividend dates for the remainder of the financial year are set out below:

Results	Announcement date	Ordinary Shares Ex-dividend date	American Depositary Shares Ex-dividend date	Record date	Last date for DRIP elections	Payable
Q2 2026	Tuesday 28 July 2026	Thursday 13 August 2026	Friday 14 August 2026	Friday 14 August 2026	Thursday 17 September 2026	Thursday 8 October 2026
Q3 2026	Wednesday 28 October 2026	Thursday 12 November 2026	Friday 13 November 2026	Friday 13 November 2026	Monday 14 December 2026	Thursday 7 January 2027
Q4 2026	Wednesday 3 February 2027	Thursday 18 February 2027	Friday 19 February 2027	Friday 19 February 2027	Tuesday 16 March 2027	Thursday 8 April 2027

These dates are indicative and may be subject to change.  

V A Whyte

Company Secretary

22 May 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: May 22, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc